|
1.
|
Haut SR, Bigal ME and Lipton RB: Chronic
disorders with episodic manifestations: focus on epilepsy and
migraine. Lancet Neurol. 5:148–157. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Russell MB and Olesen J: Migrainous
disorder and its relation to migraine without aura and migraine
with aura. A genetic epidemiological study. Cephalalgia.
16:431–435. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Lipton RB and Stewart WF: Prevalence and
impact of migraine. Neurol Clin. 15:1–13. 1997. View Article : Google Scholar
|
|
4.
|
Stovner L, Hagen K, Jensen R, et al: The
global burden of headache: a documentation of headache prevalence
and disability worldwide. Cephalalgia. 27:193–210. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Schurks M, Buring JE and Kurth T:
Migraine, migraine features, and cardiovascular disease. Headache.
50:1031–1040. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Gudmundsson LS, Scher AI, Aspelund T, et
al: Migraine with aura and risk of cardiovascular and all cause
mortality in men and women: prospective cohort study. BMJ.
341:c39662010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Goadsby PJ: Pathophysiology of migraine: A
disease of the brain. Headache. Goadsby PJ and Silberstein SD:
Butterworth-Heinemann; Boston: pp. 5–24. 1997
|
|
8.
|
Durham PL: Calcitonin gene-related peptide
(CGRP) and migraine. Headache. 46(Suppl 1): S3–S8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Goadsby PJ, Edvinsson L and Ekman R:
Vasoactive peptide release in the extracerebral circulation of
humans during migraine headache. Ann Neurol. 28:183–187. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Carroll MC, Katzman P, Alicot EM, et al:
Linkage map of the human major histocompatibility complex including
the tumor necrosis factor genes. Proc Natl Acad Sci USA.
84:8535–8539. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Wilson AG, Giovine FS and Duff GW:
Genetics of tumour necrosis factor-alpha in autoimmune, infectious,
and neoplastic diseases. J Inflamm. 45:1–12. 1995.PubMed/NCBI
|
|
12.
|
Yilmaz IA, Ozge A, Erdal ME, Edgünlü TG,
Cakmak SE and Yalin OO: Cytokine polymorphism in patients with
migraine: some suggestive clues of migraine and inflammation. Pain
Med. 11:492–497. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Mazaheri S, Hajilooi M and Rafiei A: The
G-308A promoter variant of the tumor necrosis factor-alpha gene is
associated with migraine without aura. J Neurol. 253:1589–1593.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Ates O, Kurt S, Altinisik J, Karaer H and
Sezer S: Genetic variations in tumor necrosis factor alpha,
interleukin-10 genes, and migraine susceptibility. Pain Med.
12:1464–1469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Ghosh J, Joshi G, Pradhan S and Mittal B:
Investigation of TNFA 308G > A and TNFB 252G > A
polymorphisms in genetic susceptibility to migraine. J Neurol.
257:898–904. 2010.
|
|
16.
|
Herken H, Emin EM, Mustafa Y, Kaan S and
Yildirim B: The -308 G/A polymorphism of tumor necrosis factor
alpha gene is not associated with migraine. Pain Clinic.
17:389–393. 2005. View Article : Google Scholar
|
|
17.
|
Lee KA, Jang SY, Sohn KM, Won HH, Kim MJ,
Kim JW and Chung CS: Association between a polymorphism in the
lymphotoxin-a promoter region and migraine. Headache. 47:1056–1062.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Petiti DB: Meta-Analysis, Decision
Analysis and Cost-Effectiveness Analysis: Methods for Quantitative
Synthesis in Medicine. 1st edition. Oxford University Press; New
York: 1994
|
|
20.
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Rainero I, Grimaldi LM, Salani G, Valfrè
W, Rivoiro C, Savi L and Pinessi L: Association between the tumor
necrosis factor-alpha -308 G/A gene polymorphism and migraine.
Neurology. 62:141–143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Trabace S, Brioli G, Lulli P, Morellini M,
Giacovazzo M, Cicciarelli G and Martelletti P: Tumor necrosis
factor gene polymorphism in migraine. Headache. 42:341–345. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Poscente M, Brioli G, Lulli P, Morellini
M, Martelletti P, Trabace S and Giacovazzo M: TNFA gene: the -308
promoter polymorphism in migraine. J Headache Pain. 1(Suppl 2):
S169–S171. 2000. View Article : Google Scholar
|
|
24.
|
Asuni C, Stochino ME, Cherchi A, et al:
Migraine and tumour necrosis factor gene polymorphism. An
association study in a Sardinian sample. J Neurol. 256:194–197.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Schürks M, Kurth T, Buring JE and Zee RY:
A candidate gene association study of 77 polymorphisms in migraine.
J Pain. 10:759–766. 2009.PubMed/NCBI
|
|
26.
|
Russell MB and Olesen J: Increased
familial risk and evidence of genetic factor in migraine. BMJ.
311:541–544. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Russell MB, Ulrich V, Gervil M and Olesen
J: Migraine without aura and migraine with aura are distinct
disorders. A population-based twin survey. Headache. 42:332–336.
2002. View Article : Google Scholar : PubMed/NCBI
|
